Related Experiment Videos
Integrative cardiac revitalization: bypass surgery, angioplasty, and chelation. Benefits, risks, and limitations
1University of California at Berkeley, USA.
Insights
Coronary artery disease (CAD) treatments like bypass surgery and angioplasty are palliative. EDTA chelation therapy and fish oils offer a safe cardiovascular revitalization strategy to halt disease progression and improve quality of life.
Area of Science:
- Cardiovascular Medicine
- Integrative Cardiology
- Preventive Cardiology
Background:
- Coronary artery disease (CAD) remains a leading cause of premature death globally.
- Revascularization procedures like bypass surgery and angioplasty manage severe CAD but are palliative, failing to address the underlying atherosclerosis.
- Current interventions offer symptomatic relief and survival benefits but do not halt disease progression.
Purpose of the Study:
- To explore EDTA chelation therapy and fish oils as a cardiovascular revitalization strategy.
- To evaluate the potential of integrating these therapies with conventional treatments for improved outcomes.
- To present a cost-effective approach to halt atherosclerotic progression and enhance cardiac function.
Main Methods:
- Review of existing evidence on EDTA chelation therapy and fish oils for cardiovascular health.
- Analysis of the mechanisms by which these therapies may reverse atherosclerotic damage and revitalize the myocardium.
- Conceptual framework for integrating chelation therapy and fish oils into a comprehensive cardiovascular revitalization strategy.
Main Results:
- EDTA chelation therapy shows potential for myocardial revitalization and can serve as an alternative or adjunct to revascularization.
- Fish oils are demonstrated to improve endothelial function and partially reverse atherosclerotic damage.
- Integration of chelation therapy and fish oils with nutrients, lifestyle changes, exercise, and medications offers a holistic approach.
Conclusions:
- Cardiovascular revitalization strategies incorporating EDTA chelation therapy and fish oils are safe and effective.
- These integrated approaches can halt atherosclerotic progression, restore cardiac function, extend survival, and improve quality of life.
- This strategy is cost-effective and compatible with existing revascularization modalities, offering benefits beyond palliative care.
Abstract:
Coronary artery disease (CAD) is still the main cause of premature death in the industrialized world. The revascularization modalities, bypass surgery and angioplasty, when successful provide restored blood flow to the myocardium. Bypass remains the most proven means for managing more severe cases of CAD, namely triple vessel disease with or without complications, while angioplasty works best for cases of single or double vessel disease with minimal complications. Both types of intervention partially relieve angina as they clear arterial blockage. Both save lives to an extent greater than medication alone. However, both are limited to being palliative since they fail to treat the underlying atherosclerotic occlusive process. EDTA chelation therapy appears to achieve revitalization of the myocardium, and is a viable alternative or adjunct to revascularization. Fish oils are now proven to help revitalize vessel wall endothelia and to partially reverse atherosclerotic damage. Being safe and having proven benefits, chelation therapy and fish oils can be integrated together with nutrients, lifestyle-dietary revision, exercise, and medications as necessary, into a cardiovascular revitalization strategy. Cardiovascular revitalization would be highly cost-effective and procedurally compatible with the revascularization modalities, while extending beyond revascularization to halt atherosclerotic progression, restore cardiac functionality, extend survival, and improve quality of life.